The development highlights ongoing regulatory efforts to address cost pressures and execution challenges in India’s rapidly growing private health insurance market.
Robotaxis are giving commercial shape to APAC’s broader AV market, but insurers remain constrained by limited data, fragmented regulation, and unresolved liability questions.
